Lexicon Genetics Closes Acquisition of Coelacanth | GenomeWeb

NEW YORK, July 13 – Lexicon Genetics of The Woodlands, Texas, has closed the deal to acquire Coelacanth in a stock transaction valued at $32 million.

Under the terms of the final merger agreement announced Thursday, Lexicon will distribute 2,918,991 shares of common stock to Coelacanth stockholders. The deal is based on Lexicon’s average closing price of $10.9625 per share during the 30 days ending three days prior to the effective date of the merger.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.